First Light Biosciences welcomes you to join us at the 28th Annual ECCMID congress in Madrid, April 21-24, 2018. First Light will be presenting our latest work highlighting our latest the advances in the detection of Clostridium difficile testing. CEO Don Straus will be in attendance and welcomes you to learn more about our technology and ways in which First Light aims to advance health care practices to improve detection of deadly hospital associated infections.
Title: A rapid single molecule counting method sensitively detects Clostridium difficile toxin B directly in stool samples
Session Name: C difficile and other Gram-positives, ePoster Mini Oral Session
Date and Time: April 21st 4:30-7:30 PM ( Our session starts promptly at 5:12-5:17 PM)
Location: ePoster Arena 1